(13 December 2016) Fullshare Holdings Limited (“Fullshare Holdings” or the “Company”, which together with its subsidiaries, is referred to as the “Group”; SEHK stock code: 607), which is principally engaged in property development, provision of green building services, investment and the business of healthcare products and services, announces today that it has signed an agreement to subscribe for 45,411,600 H shares of Nanjing Sinolife United Company Limited (“Sinolife United”, SEHK stock code: 3332) for HK$73,122,676, or at HK$1.61 per H share in cash. The subscription price represents a discount of approximately 12.02% to the closing price of HK$1.83 per H share of Sinolife United as quoted on the Stock Exchange on 13 December 2016. The new shares will be equal to 16.67% of the enlarged issued H share capital and 4.8% of the total enlarged share capital (comprising the mainland China-listed A shares and the H shares) of Sinolife United.

The Group also announces that it has signed an agreement to subscribe for 40,000,000 new shares of C&D International Investment Group Limited (“C&D”, SEHK stock code: 1908) for HK$158.8 million, or at HK$3.97 per share in cash. The Group will hold approximately 9.35% of the enlarged issued share capital of C&D.

Sinolife United is a leading manufacturer of nutritional supplements and health food products in mainland China and also sells such products. According to Sinolife United’s 2016 interim report, the company has a diversified sales network that covered 27 cities in mainland China, including those in 13 provinces and the municipalities under the direct jurisdiction of the central government as of 30 June 2016. Meanwhile, C&D’s principal businesses include property development, operation and management as well as advisory service.

Mr. Ji Changqun, Executive Director, Chairman and CEO of Fullshare Holdings said, “Fullshare devotes itself to developing an integrated business of healthcare and healthy lifestyle through in-depth collaboration with industry leaders. The cooperation with Sinolife United will enrich the mix of the Group’s products and services and expand its share of China’s market for healthcare consumables. While expanding the mainland market, the Group and Sinolife United will actively explore opportunities for investing in the manufacturing of high-quality health products in Australia, New Zealand and Singapore. On the other hand, the Group is committed to the development of green construction. The business of the C&D can generate synergy with the Group’s existing businesses of property development and green building service.”